| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0575 | Am3506 | Potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH) |
|
| DCC0576 | Am4668 | Potent FFA1 (GPR40) agonist, inhibiting insulin secretion from isolated pancreatic islets and reducing blood glucose levels |
|
| DCC0577 | Am6701 | Novel highly potent inhibitor of human alpha/beta hydrolase domain 6 (hABHD6) |
|
| DCC0578 | Ambenonium Chloride | Reversible cholinesterase inhibitor used in the management of myasthenia gravis |
|
| DCC0579 | Ambigol A | Antibiotic against Serratia sp. ATCC 39006 (S39006) strain |
|
| DCC0580 | Ambigol C | Downregulator of genes associated with the translation machinery and fatty acid biosynthesis in Serratia, increasing expression of genes related to the uptake of L-proline after RNA-Seq of S39006 to be treated |
|
| DCC0581 | Amc-01 | Novel inducer of inactivation of eIF2-alpha by phosphorylating serine residue 51 in a dose- and time-dependent manner |
|
| DCC0582 | AMD3100 Octahydrochloride Bulk | 0 |
|
| DCC0583 | Amde-1 | Novel modulator of autophagy activity, triggering autophagy in an Atg5-dependent manner, recruiting Atg16 to the pre-autophagosomal site and causing LC3 lipidation |
|
| DCC0584 | Americanin A | Natural thrombin (E.C. 3.4.21.5) inhibitor, suppressing melanin synthesis, regulating the ATM/ATR signaling pathway and the Skp2-p27 axis in human colon cancer cells |
|
| DCC0585 | Amg0074 | Novel PDE10 antagonist |
|
| DCC0586 | Amg-0347 | Novel transient receptor potential type V1 (TRPV1) receptor antagonist |
|
| DCC0587 | Amg-0696 | Novel disrupter of glucokinase-glucokinase regulatory protein (GK-GKRP) binding, inducing GK translocation from the nucleus to the cytoplasm in rats and blood glucose reduction in mice |
|
| DCC0588 | Amg-151 | Novel glucokinase activator, decreasing fasting and postprandial glycaemia |
|
| DCC0589 | Amg-18 Hydrochloride | Novel selective IRE1α inhibitor |
|
| DCC0590 | Amg21629 | Potent and selective TRPV1 antagonist |
|
| DCC0591 | Amg222 | Novel potent DPP-IV inhibitor |
|
| DCC0592 | Amg-25 | Novel potent and selective inhibitor of c-Kit |
|
| DCC0593 | Sotorasib racemate Featured | Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib, a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research. |
|
| DCC0594 | Amg-7549 | Novel Disrupter of Glucokinase−Glucokinase Regulatory Protein (GK−GKRP) Binding |
|
| DCC0595 | Amg-7980 | Novel highly specific phosphodiesterase 10A (PDE10A) ligand with good uptake in the striatum |
|
| DCC0596 | Amg8163 | Vanilloid receptor TRPV1 antagonist |
|
| DCC0597 | amg8562 | Novel vanilloid receptor TRPV1 modulator |
|
| DCC0598 | Amg8563 | Novel vanilloid receptor TRPV1 modulator |
|
| DCC0599 | Amg9090 | Specific transient receptor potential ankyrin 1 (TRPA1) antagonist |
|
| DCC0600 | Ami-5 Trihydrate | Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $15.75 Total: $1,575.00 50 $18.20 Total: $910.00 25 $21.35 Total: $533.75 10 $25.20 Total: $252.00 5 $29.75 Total: $148.75 |
|
| DCC0601 | Amids-stilbene | Cysteine trapping agent, protecting cysteines exposed to the aqueous environment from subsequently added mal-PEG |
|
| DCC0602 | Amifostine Hydrate | Radiation-protective agent, causing splenic vasodilation and blocking autonomic ganglia |
|
| DCC0603 | Aminoprofen | NSAID (non-steroidal anti-inflammatory drug) and non selective COX inhibitor |
|
| DCC0604 | Amiselimod | Immunomodulator |
|
